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The Drosophila Orphan Nuclear Receptor DHR38
Mediates an Atypical Ecdysteroid Signaling Pathway
that seem to be common to all NGFI-B subfamily mem-
bers. Taken together, these data reveal the existence
of a separate structural class of nuclear receptors that
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Figure 1. DHR38 and EcR Mediate Distinct
Ecdysteroid-Signaling Pathways
(A–D) EcR- and DHR38-dependent transacti-
vation was assayed in SL2 cells cotransfected
with insect expression vectors for the various
receptor combinations shown (RLU, relative
light units). Reporter plasmids used were
adh-UASx3-Luc (in [A], [B], and [D]) and adh-
hsp27-EcRE-Luc in (C). (A) The GAL4-EcR/
RXR heterodimer (left) and the GAL4-DHR38/
RXR heterodimer (right) respond differently to
the RXR agonist (LG268) and the ecdysteroid
muristerone A (Mur A). (B) GAL4-DHR38/RXR-
dependent transcriptional activity requires the
DHR38 AF-2 domain. (C) RNAi against EcR
abolishes ecdysteroid-dependent transcrip-
tion of the hsp27-EcRE that is mediated by
either endogenous (left) or transfected (right)
EcR. Increasing amounts of muristerone A (0,
0.1, 0.3, and 1 M) are indicated by shaded
bars. (D) RNAi against EcR selectively elimi-
nates transactivation of GAL4-EcR/RXR (right),
but not GAL4-DHR38/RXR (left) induced by
LG268 (10 nM) and muristerone A (100 nM).
mone (Fisk and Thummel 1995; Kozlova et al., 1998). (4) vious work has shown that some RXR heterodimers
require sensitization with ligand for one receptor beforeBoth DHR38 and usp mutant flies have abnormalities
the partner receptor can become ligand responsivein cuticle formation that are not seen in EcR mutants,
(Botling et al., 1997).thereby uncoupling the action of the two receptor het-
To screen for a DHR38 ecdysteroid response, tran-erodimer complexes and suggesting they may govern
sient cotransfections were performed in the Drosophiladistinct ecdysteroid signaling pathways (Kozlova et al.,
SL2 cell line using chimeric GAL4-receptor proteins and1998; Hall and Thummel, 1998). Taken together, these
a GAL4-responsive luciferase reporter gene (Baker etfindings raise the possibility that DHR38 participates in
al., 2000). In this assay, GAL4-EcR and GAL4-DHR38an ecdysteroid response pathway that is different from
were screened in the presence of RXR, the syntheticthe one transduced by the EcR/USP heterodimer.
rexinoid LG268 (Boehm et al., 1995), and the potentIn this paper, we report the characterization of a sec-
plant ecdysteroid muristerone A (Figure 1A). Similar toond ecdysteroid signaling pathway in Drosophila medi-
previous work (Baker et al., 2000), the GAL4-EcR/RXRated by DHR38. This signaling pathway requires hetero-
heterodimer responded to 100 nM muristerone A asdimerization with USP and utilizes a mechanism that
expected but was not activated significantly by LG268does not involve direct binding of either ecdysteroids
alone (Figure 1A, left). Addition of both ligands resultedor canonical cofactors to DHR38. To further explore the
in only a modest increase in EcR/RXR activity (Figurebasis for this atypical mechanism, we also show the
1A, left). In contrast, GAL4-DHR38/RXR, which is knownX-ray crystal structure of DHR38, which differs from all
to have a potent basal activity (Baker et al., 2000; Suther-previously characterized nuclear receptor structures by
land et al., 1995), was not induced by the addition oflacking both the signature ligand binding pocket and
ecdysteroid alone but, instead, exhibited a strong, dose-coactivator binding site. Extrapolation of the DHR38
dependent response to LG268 (Figure 1A, right). Rexi-structure to other members of the NGFI-B receptor sub-
noid activation of the DHR38/RXR heterodimer is con-family suggests that this structural feature has been
sistent with the rexinoid response seen with otherconserved throughout evolution.
NGFI-B family members when paired with RXR (Per-
lmann and Jansson, 1995). Surprisingly, however, there
Results was a significant, 3- to 4-fold response to muristerone
A when it was added together with LG268 (Figure 1A,
DHR38 Functions as an Ecdysteroid Sensor right). A similar response was obtained with the endoge-
To investigate the possibility that DHR38 may function nous insect ecdysteroid 20E (Figure 1B). Both rexinoid
in an ecdysteroid-mediated transcriptional pathway, we and ecdysteroid responses were abolished when a
developed a screening assay in which DHR38 was het- GAL4-DHR38 construct was utilized that lacks the li-
erodimerized with ligand-activated RXR. The feasibility gand-dependent activation function-2 (AF-2) domain.
of this approach was based on the finding that RXR can Identical results were obtained (i.e., loss of rexinoid and
substitute for USP as a productive heterodimeric partner ecdysteroid response) when the AF-2 domain of RXR
for EcR (Thomas et al., 1993; see also Figure 1A). A was also deleted (data not shown). These data suggest
distinct advantage of substituting RXR for USP is that that the DHR38 heterodimeric complex is responsive to
although ligands for USP are not known, several potent ecdysteroid but, like other RXR heterodimers, it requires
RXR ligands (i.e., rexinoids) have been characterized. transactivation of both receptor partners for full agonist
We reasoned that assaying DHR38 activity in the presence activity.
The results above revealed the possible existence ofof rexinoid-activated RXR may be important because pre-
Structure and Function of DHR38
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Figure 2. The DHR38/RXR Heterodimer Is a Promiscuous Sensor of Ecdysteroids
(A–C) Activity of GAL4-EcR versus GAL4-DHR38 in transfections performed in SL2 cells. (A) GAL4-EcR and GAL4-DHR38 respond to a distinct
set of natural and synthetic ecdysteroids. Note that the ecdysteroid response of GAL4-DHR38 required heterodimerization with RXR and
rexinoid (10 nM LG268). Dotted white line represents the basal response in the absence of any ecdysteroid. (B) Dose-response curves for
natural ecdysone metabolites activating GAL4-EcR/RXR (left) and GAL4-DHR38/RXR (right) in the presence of 10 nM LG268. (C) Dose-response
curves for natural makisterone metabolites activating GAL4-EcR/RXR (left) and GAL4-DHR38/RXR (right) in the presence 10 nM LG268.
two ecdysteroid signaling pathways, one mediated by the endogenous ecdysteroids 20E and makisterone A
and the plant ecdysteroids muristerone A, ponasteroneEcR and the other by DHR38. To begin to delineate
the specificity of the DHR38 pathway and show that it A, and cyasterone. In marked contrast, the GAL4-
DHR38/RXR response was promiscuous for several dif-functions independently of the EcR pathway, we utilized
double-stranded RNA (dsRNA) directed against the cod- ferent ecdysteroids when LG268 was included as a coa-
gonist (Figure 2A). In addition to the compounds thating region of the EcR ligand binding domain to reduce
the expression of endogenous EcR in the SL2 cell assay. activated EcR, at least six other ecdysteroids (-ecdy-
sone, 3-epi-20E, 2-deoxy-20E, 3-dehydromakisteroneAs shown in Figure 1C, treatment of SL2 cells with in-
creasing amounts of EcR dsRNA completely eliminated A, 3-epimakisterone A, and 3-dehydro-20-deoxyponst-
erone) also exhibited significant DHR38-dependent ac-muristerone-A-dependent transcription when tested us-
ing endogenous EcR/USP heterodimers on an hsp27- tivity. Dose-response profiles demonstrated that all of
these compounds were more potent agonists for DHR38EcRE reporter gene. This RNAi-mediated repression of
the EcR-dependent response also completely blocked than for EcR (Figures 2B and 2C). In fact, 20E, which is
believed to be the endogenous hormone agonist forthe activity of exogenously transfected EcR (Figure 1C,
right) and GAL4-EcR (Figure 1D, left). In contrast, under EcR, exhibited a 100-fold greater potency for DHR38-
dependent transcription. These data suggest that thethe same experimental conditions where the EcR re-
sponse was abolished, the GAL4-DHR38/RXR hetero- DHR38/RXR heterodimer is a potent sensor of a distinct
class of physiologically relevant ecdysteroids.dimer was fully responsive to ecdysteroid and LG268.
These results demonstrate that the DHR38 response to
ecdysteroids is independent of EcR.
To define the spectrum of potential DHR38 agonists Activation of the DHR38/USP Heterodimer by
Ecdysteroids Requires Transactivated USPand further delineate the differential ecdysteroidal re-
sponse of DHR38 and EcR, a panel of naturally occurring An unusual characteristic of the DHR38/RXR hetero-
dimer is that it required transactivation of both receptorsDrosophila ecdysteroids, phytoecdysteroids, synthetic
ecdysteroids, and a synthetic juvenile hormone (metho- to elicit an ecdysteroid response. In particular, the
DHR38/RXR heterodimer failed to respond to ecdyste-prene acid) were tested for activity using the reporter
gene assay described above. SL2 cells were transfected roid in the absence of ligand-activated RXR. Interest-
ingly, DHR38 also failed to respond to ecdysteroid whenwith either GAL4-EcR or GAL4-DHR38 plus RXR and
tested for agonist activity in the presence of 10 nM USP, the physiologic partner of DHR38, was used instead
of RXR (Figure 3A). These results raise the intriguingLG268 (Figure 2A). Consistent with previous results
(Baker et al., 2000), GAL4-EcR responded selectively to possibility that USP, like RXR, must also be transacti-
Cell
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DHR38 Is Activated by Ecdysteroids
in Organ Culture
To test the prediction that DHR38 is activated by ecdy-
steroids in Drosophila, we created transgenic flies that
carry a heat-inducible hs-GAL4-DHR38 transgene in
combination with a GAL4-dependent UAS-nlacZ re-
porter gene. Since target genes for DHR38 in the fly
are unknown, this model permits us to assay DHR38
transactivation directly in fly tissues. This transgenic fly
model has been used to follow the ecdysteroid-depen-
dent activation patterns of the EcR and USP in Drosoph-
ila and has provided data consistent with the known
biochemical and genetic activities of the full-length re-
ceptors in vivo (Kozlova and Thummel, 2002). This strat-
egy has also been employed to track ligand-dependent
activation of the RAR and RXR ligand binding domains
in the mouse central nervous system (Solomin et al.,
1998). To determine if GAL4-DHR38 is activated by ec-
dysteroids, third instar larval organs from this transgenic
line were dissected at 8 hr before puparium formation
and cultured in the presence of either -ecdysone or
3-epi-20E, two ecdysteroids that were shown to activate
DHR38, but not EcR in SL2 cells (Figure 2). In the pres-
ence of 1 M -ecdysone, significant activation above
background was seen for GAL4-DHR38 (Figures 4C and
4D). In contrast, these ecdysteroids had no effect on
GAL4-EcR (Figures 4A and 4B), although this same
transgenic line showed robust activation by 20E (Koz-
lova and Thummel, 2002). GAL4-DHR38 was also acti-
vated by 3-epi-20E in both the epidermis and fat body
(Figures 4E–4H), consistent with the ability of this ago-
Figure 3. Heterodimerization with Transactivated USP Enables nist to selectively activate DHR38 in SL2 cells (Figure
DHR38 Responsiveness to Ecdysteroids 2). These organs contain significant amounts of endoge-
(A) GAL4-DHR38 responds to ecdysteroids when dimerized with nous USP (Henrich et al., 1994), consistent with the
VP16-USP, a constitutively active form of USP. Assays were per- interpretation that GAL4-DHR38 ecdysteroid activation
formed in SL2 cells expressing GAL4-DHR38 in combination with
is dependent on heterodimerization with a USP partner.RXR, USP, VP16, or VP16-USP. VP16-USP alone showed no activity
Although similar results were seen in several indepen-in this assay.
dent experiments, not all hs-GAL4-DHR38; UAS-nlacZ(B) Dose-response curves for ecdysone metabolites (left) and maki-
sterone metabolites (right) activating the GAL4-DHR38/VP16-USP animals displayed robust activation, indicating that a
heterodimer in transfected SL2 cells. specific stage might be competent to respond to the
hormone. In agreement with this idea, a complex and
dynamic pattern of GAL4-DHR38 activation can be seen
in untreated animals (T.K., unpublished data). This ob-vated (e.g., by ligand) in order to enable the ecdysteroid
servation is consistent with the notion that the endoge-response. We attempted to address this question by
nous DHR38 response may be spatially and temporallyusing VP16-USP, a constitutively active form of USP
regulated by the presence of a number of factors, includ-that circumvents the requirement for USP ligand by fus-
ing ecdysteroids, DHR38/USP-specific coactivators,ing the strong transcriptional activation domain of the
and potentially a USP ligand.herpes simplex viral protein-16 (VP16) to USP. As ex-
pected, in the absence of agonist, the GAL4-DHR38/
VP16-USP heterodimer showed a high constitutive level Structure of DHR38
of basal activity that effectively mimicked ligand-acti- The results above suggested that DHR38 may function
vated USP (Figure 3A). Importantly, the addition of muri- as an ecdysteroid receptor and, like other nuclear recep-
sterone A to the GAL4-DHR38/VP16-USP heterodimer tors, recruit coactivators upon ligand binding. However,
elicited a significant increase in reporter gene activity, despite several attempts using a variety of techniques,
analogous to the effect seen with LG268-activated GAL4- including direct radioligand binding and cofactor recruit-
DHR38/RXR. Similar to the results obtained above with ment assays (Makishima et al., 1999, 2002), we were
ligand-activated RXR (Figures 2C and 2D), the GAL4- unable to demonstrate that DHR38, RXR, or USP (alone
DHR38/VP16-USP heterodimer responded to a wide va- or as a heterodimer) directly binds any of the potent
riety of ecdysteroids at comparably low concentrations ecdysteroid agonists or their metabolites (Baker et al.,
(Figures 3B and 3C). These results support the idea 2000; data not shown). In addition, we were unable to
that DHR38 mediates a distinct heterodimer-dependent detect interactions between DHR38 and any of the
known nuclear receptor cofactors (Rosenfeld and Glass,ecdysteroid signaling pathway.
Structure and Function of DHR38
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Figure 4. GAL4-DHR38 Is Activated by Ecdy-
steroids in Drosophila Larval Organ Culture
(A–H) Third instar larval organs dissected
from either heat-treated hs-GAL4-EcR; UAS-
nlacZ or hs-GAL4-DHR38; UAS-nlacZ animals
were cultured in the absence or presence of
ecdysteroids and processed for histochemi-
cal staining. GAL4-EcR is not activated in ei-
ther the absence (A) or presence (B) of 1 M
-ecdysone. In contrast, GAL4-DHR38 is sig-
nificantly activated by 1 M -ecdysone in
epidermis (D) above its basal level (C). GAL4-
DHR38 is also activated by 1 M 3-epi-20-
hydroxyecdysone (F and H) above its basal
level (E and G) in epidermis (E and F) and fat
body (G and H). The UAS-nlacZ reporter alone
is not ecdysteroid responsive either in vivo
or in organ culture (data not shown).
2001) including SRC-1, GRIP1, ACTR, or NCoR (data not with cell dimensions a  78.38 A˚, b  82.23 A˚, c 
84.15 A˚,       90 and two molecules in theshown). Likewise, mammalian NGFI-B family members
have also been shown to lack interactions with known asymmetric unit. Continuous electron density was ob-
served throughout the protein except for the nine aminocofactors (Castro et al., 1999; Wansa et al., 2002; Maira
et al., 2003), which has been suggested to be due to the acids of the 6His tag at the N terminus and the last four
amino acids at the C terminus. No significant differenceslack of a coactivator interaction surface on the receptor
(Wansa et al., 2002). Taken together, these findings sug- were observed between the two molecules in the asym-
metric unit.gest the existence of an atypical signal transduction
mechanism that governs DHR38 transactivation and The overall architecture of the DHR38 ligand binding
domain (Figures 5A and 5B) is similar to other membersthat apparently does not require direct binding of ligand
or known coactivators. To begin to explore this mecha- of the nuclear receptor family (Bourguet et al., 1995).
The structure consists of 11  helices with a small three-nism in more detail, the X-ray crystal structure of the
Drosophilia DHR38 ligand binding domain was solved stranded  sheet arranged in a three-layer helical sand-
wich. Helices H4, H5, H8, and H9 are packed between(residues 841–1073 in Kozlova et al., 1998) to an R factor
of 20% at 2.3 A˚ resolution using MAD phasing (Table helices H1 and H3 on one side, with H7 and H10 on the
other side. DHR38 does not contain helix H2 but has an1). Crystals of DHR38 have the space group P212121,
Table 1. Crystallographic Data and Refinement Statistics
Protein Native Selenomethionine
Wavelength (A˚) 1.54 0.9792 0.9794 0.9840
Resolution (A˚) 50.0–2.3 50.0–2.3 50.0–2.3 50.0–2.3
Observations 189296 202035 193530 189325
Unique reflections 23421 25602 25410 25166
Completenessb (%) 94.6 99.3 98 98
Rsyma,b (%) 7.5 7.7 9.3 6.6
Rfactorc(%) 20
Rfreed(%) 24
Rms bonds 0.007 A˚
Rms angles 1.11
a Rsym  hkl|I	
I|II, where I is the observed intensity and 
I is the average intensity from observations of symmetry-related reflections.
b Value in parentheses is for the highest resolution shell.
c Rfactor  hkl|Fobs|	|Fcalc||/|Fobs|, where Fobs and Fcalc are the observed and calculated structure factor amplitudes, respectively, for the hkl
reflections.
d Rfree is calculated for a set of reflections that were not included in atomic refinement.
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additional short helical segment between helices H9 and
H10. The AF-2 helix of DHR38 (residues 1060–1069) was
found in the “active” conformation, characteristic of ag-
onist bound nuclear receptors.
In many nuclear receptor ligand binding domain crys-
tal structures, the protein exists as a homo- or hetero-
dimer with an extensive dimer interface along helix H10
(Bourguet et al., 1995; Brzozowski et al., 1997; Nolte et
al., 1998; Bourguet et al., 2000; Gampe et al., 2000;
Wisely et al., 2002). In the DHR38 structure, the protein
appears as a monomer despite the fact that two mole-
cules are found in the asymmetric unit. DHR38 is known
to bind to specific response elements as a monomer as
well as a heterodimer with USP. No significant crystal
contacts were observed in the structure that would sug-
gest a biologically relevant homodimer interface. This
finding is consistent with the results of size exclusion
chromatography using the crystallography construct.
Although the structural basis of DHR38’s ability to het-
erodimerize with USP must await the structure of the
DHR38/USP complex, DHR38 does contain the consen-
sus heterodimerization motif of φ K K  R
in the first half of helix H10, whereφ the hydrophobic
aromatic residues Phe, Trp, or Tyr;   a hydrophobic
aliphatic residue with preference for Met, Leu, Val, Pro,
Ala, or Ile; and  the acidic residue Asp or Glu (Gampe
et al., 2000). This motif corresponds to F SRLL GKLP E
LRSL in DHR38 (residues 1027–1040).
DHR38 Lacks a Conventional Ligand Binding Pocket
Of significant interest was the finding that the apo-
DHR38 structure does not contain a well-defined ligand
binding site. The side chains of four phenylalanines
(F881, F922, F939, and F954) point into the interior of
the pocket (Figures 5A and 5B) and essentially fill the
Figure 5. Structure of the DHR38 Ligand Binding Domain entire space. Calculation of the volume of the cavity
(A and B) The DHR38 ligand binding domain is composed of 11  within the putative binding pocket revealed that the
helices (red tubes) and a small three-stranded  sheet (yellow largest contiguous pocket is only 30 A˚3, which is too
arrows) arranged in a three-layer helical sandwich. Four Phe resi- small to allow binding of any organic small molecule
dues that fill the ligand binding site and Arg929 are shown in space
(Figure 5C). Three of the four phenylalanines adopt thefilling representation colored by atom type (carbon, green; nitrogen,
only available low energy conformations, while theblue). The major  helices are numbered according to convention
(Bourguet et al., 1995). fourth can only move within a single plane before en-
(C) Closeup view of the ligand pocket. The four Phe residues that countering a significant steric barrier (Figure 5D). Thus,
fill the pocket are labeled. The white dot surface represents the it does not appear that any simple structural changes
calculated volume of the residual cavity within the ligand binding
are available that might open up the binding pocket fordomain.
access to a potential ligand.(D) Ramachandran plot of the quantum mechanical energy surface
Most nuclear receptors contain a conserved argininefor the four Phe residues. Conformations of 1 and 2 angles with
the lowest energy are colored blue, with higher energies colored within helix H5 that serves to anchor and correctly posi-
according to the scale, where energies are given in kcal/mole. tion ligands within the predominantly hydrophobic li-
(E) Sequence identities of the ligand binding domains within the gand binding pocket. While this arginine is conserved
DHR38/NGFI-B family. Pairwise identities between DHR38 and the
in DHR38 (R929), its side chain points out toward solventhuman NGFI-B subtypes are shown at the vertices of the triangle.
rather than toward the interior of the protein. The  sheetPairwise identities between the NGFI-B subtypes are shown along
the faces of the triangle. packs tightly against the end of helix H5, excluding R929
(F) Conservation of the four Phe residues that fill the binding pocket. from the potential binding pocket (Figures 5A and 5B).
The amino acid numbering for each of the phenylalanine residues The absence of a ligand binding pocket is consistent
in DHR38 and the human NGFI-B subtypes is given.
with our inability to detect ecdysteroid binding to(G) The DHR38 ligand binding domain showing the residues that
DHR38. We conclude from these data that ecdysteroidcompose the core of the ligand binding pocket in wire-frame repre-
sentation. Residues that are conserved between DHR38 and the activation of the DHR38/USP heterodimer must occur
NGFI-B family members are shown in white, while nonconserved through an alternative mechanism that does not involve
residues are shown in dark blue. direct binding of the agonist to the receptor complex.
The details of this mechanism are currently under study.
Structure and Function of DHR38
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Conservation between DHR38 and Mammalian
NGFI-B Family Members
DHR38 has high sequence identity with the ligand bind-
ing domain of the three human NGFI-B subfamily mem-
bers. A pairwise analysis of these sequences showed
that DHR38 has the same level of conservation with each
of the human NGFI-B family members as the human
receptor subtypes have amongst themselves (Figure 5E),
suggesting that each of these four receptors evolved from
a common ancestor. Further analysis of the DHR38 and
mammalian sequences revealed that the four phenylala-
nines that fill the ligand pocket are conserved (Figure
5F), as are almost all the amino acids that make up
the core of the ligand binding domain (Figure 5G). The
remarkable conservation between these receptors sug-
gests that the vertebrate NGFI-B subfamily members
also do not have a conventional ligand binding pocket.
DHR38 Lacks a Conventional Coactivator Binding
Site and Has an Atypical AF-2 Helix
The coactivator binding site in other nuclear receptors
consists of a hydrophobic groove formed by helices H3,
H4, H5, and the AF-2 helix. In these receptors, the LXXLL
motif of the coactivator is positioned within the groove
by a charge-clamp interaction involving a highly con-
served glutamic acid on AF-2 and a lysine on helix H3
(Darimont et al., 1998; Nolte et al., 1998; Shiau et al.,
1998; Gampe et al., 2000; Xu et al., 2001). Sequence
alignments of the DHR38/NGFI-B family with other nu-
clear receptors indicates that the charged clamp resi-
dues are not conserved. The conserved glutamic acid
on the AF-2 is an asparagine in DHR38 (N1065) and a
lysine in the mammalian NGFI-B receptors. The con-
served lysine on helix H3 is a glutamic acid in both
Figure 6. Structural Features that Preclude Binding of Coactivator
DHR38 (E897) and its mammalian orthologs. Interest- Proteins to DHR38
ingly, in the DHR38 structure, the AF-2 helix is shifted by
(A) Overlay of DHR38 with the RXR/SRC1 complex (Gampe et al.,
one turn relative to its position in other nuclear receptor 2000) showing the shift in the C-terminal AF-2 helix. The DHR38
ligand binding structures (Figure 6A). The AF-2 helix is protein backbone is shown as a blue ribbon, with the AF-2 helix in
held in this position by a series of hydrophobic contacts red. The RXR protein backbone is shown as a yellow ribbon, with
the AF-2 helix in gold. The SRC1 coactivator fragment is shown inwith the main body of the ligand binding domain. The
magenta. N1065 from DHR38 and E453 from RXR are highlighted.side chains of I1063 and M1066 are buried completely
(B and C) DHR38 lacks a binding groove for LXXLL motifs. (B) Space-at the interface, with the M1066 side chain packing in
filling view of the surface of PPAR with the SRC1 fragment showna hydrophobic depression created by the side chains
as a stick model. Note that the Leu residues of the LXXLL motif are
of L885, L918, L1045, and I1048. Due to the shift of the buried into the groove along the surface of PPAR that is formed
AF-2 helix in DHR38, A1061, rather than N1065, sits at by hydrophobic pockets. (C) The corresponding surface of DHR38
the same position as the conserved glutamic acid of the is shown. One of the Leu binding pockets (a) is partially blocked,
and the bottom of the coactivator groove (b) is not accessible.charge clamp. These features result in the loss of the
charge clamp in DHR38. In addition, the hydrophobic
cleft that makes up the LXXLL motif binding site is
Discussionblocked by a number of hydrophilic residues in DHR38.
The side chains of L893 and N1065 point into the groove,
In the present work, we provide evidence for the exis-partially blocking one of the leucine binding pockets
tence of an ecdysteroid signaling pathway mediated byand closing off one end of the groove (Figures 6B and
the orphan nuclear receptor DHR38. The existence of6C). Thus, it is unlikely that the DHR38 AF-2 helix can
this pathway is supported by four independent experi-stabilize the binding of coactivator proteins through the
mental findings. First, transactivation assays in insectLXXLL coactivator motif. These observations may ex-
cells demonstrated that a distinct group of endogenousplain why none of the well-characterized coactivator
ecdysteroids, several with no previously known func-proteins for all other nuclear receptors have been shown
tion, can potentiate DHR38-dependent transcriptionto interact with any members of the DHR38/NGFI-B fam-
when heterodimerized with a preactivated partner (i.e.,ily. Taken together with the finding that these orphan
rexinoid bound RXR or VP16-USP). Second, organ ex-nuclear receptors lack a conventional ligand binding
plants from transgenic flies bearing a DHR38-specificpocket, the structural analysis supports the notion that
reporter gene were shown to be similarly responsive tothese receptors must use an alternate mechanism for
effecting transactivation of gene expression. ecdysteroids, indicating that this pathway can function
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in vivo. Importantly, the specificity of the DHR38 ecdy- An interesting feature of the DHR38 response is the
broad specificity and increased sensitivity that a numbersteroid activators and the use of RNAi methodology
have excluded the involvement of EcR in mediating this of ecdysteroids have for DHR38 compared to the pre-
viously described signaling pathway mediated by EcR.response. Third, neither the ecdysteroid agonists nor
any of the known nuclear receptor coactivators were Indeed, even the response to 20E appears to be an order
of magnitude more potent for DHR38 than for EcR. Thus,capable of binding directly to DHR38. Fourth, X-ray crys-
tallographic structure analysis of the DHR38 ligand bind- discovery of the DHR38 response pathway may not only
provide a mechanism of action for other ecdysteroidsing domain showed that DHR38 lacks the classic binding
sites for either a ligand or a conventional coactivator, in insects, but may also provide a means of augmenting
the ecdysteroid-mediated functions of EcR at specificfeatures that are hallmarks of all other known inducible
nuclear receptors. As discussed below, these findings stages in the life cycle.
Another striking feature of the DHR38 response isprovide compelling evidence for an atypical nuclear re-
ceptor transcriptional signaling pathway that mediates that it requires coactivation of its heterodimer partner
to become competent for transcriptional activation viaecdysteroid responses in insects.
ecdysteroids. The finding that VP16-USP was able to
substitute for ligand-activated RXR in our transfectionIntegration of the DHR38 Signal Transduction Pathway
assays is intriguing and suggests that in vivo, wild-typewith Known Ecdysteroid Responses
USP is capable of activation by ligand or some otherThe insect hemolymph carries a wide range of endoge-
coactivation mechanism. The existence of a ligand fornous ecdysteroids, some of which are only present at
USP is supported by X-ray crystal data on the USPspecific stages during development. These may be sup-
ligand binding domain showing the presence of a largeplemented by phytoecdysteroids that can enter the ani-
hydrophobic pocket that can be occupied by lipophilicmal through its diet (Riddiford, 1996; Dinan, 2001; Gilbert
ligands (Billas et al., 2001; Clayton et al., 2001). Theet al., 2002). Until recently, it was thought that the vast
observation that the DHR38 ecdysteroid response canmajority of these compounds were unable to elicit a
occur in larval organs that contain wild-type USP sup-biological response. Mounting evidence, however, indi-
ports this hypothesis (Figure 4). Identification of the USPcates that alternate transcriptional pathways exist that
ligand and/or coactivator represents a critical next stepare driven by ecdysteroids other than 20E. Coordinate
toward defining the mechanism of DHR38 action.changes in ecdysteroid-regulated gene expression oc-
cur at several stages in the Drosophila life cycle at times
when the 20E titer is known to be low (Andres and Cher- Biochemical and Structural Studies Reveal
a Nonclassical Mechanism of Nuclearbas, 1992; Andres et al., 1993; Benyajati et al., 1983;
Mougneau et al., 1993; A. Sullivan and C.S.T., unpub- Receptor Activation
DHR38’s distinct ecdysteroid-regulated activity pointslished data). In addition, the let-7 and miR-125 small
temporal RNAs are induced at puparium formation in to a role that is substantially different from that of EcR,
both in terms of ligand specificity and mechanism of actionprecise synchrony with the E74A 20E-inducible gene,
but in a manner that is independent of either 20E or (Koelle, 1992; Thomas et al., 1993; Yao et al., 1993). Al-
though both receptors require heterodimerization withEcR (Bashirullah et al., 2003). Of particular relevance to
DHR38 functions, Champlin and Truman (1998) have USP to be ecdysteroid responsive, only the EcR re-
sponse appears to require conventional binding of theshown that -ecdysone drives neuroblast proliferation
during early pupal development in the hornworm Man- ecdysteroid agonist. Furthermore, the role of USP in
the EcR heterodimer is that of a silent partner (i.e., theduca sexta, providing in vivo evidence that this hormone
is responsible for a specific response in insects. Simi- transcriptional activity of USP is dispensable for the
ecdysteroid response). In contrast, we have shown thatlarly, 3-dehydro-20E was shown to have a potency indis-
tinguishable from 20E in Manduca (Hiruma et al., 1997) the DHR38 pathway requires transcriptional activation
of both itself and its heterodimeric partner. Surprisingly,and was also observed to have high activity in Drosoph-
ila larval fat body (Somme´-Martin et al., 1990), while however, this response occurs in the absence of ecdy-
steroid binding directly to receptor, implying the exis-Rachinsky et al. (1990) noted that makisterone A and
not 20E is the major ecdysteroid present during the last tence of a nonclassical mechanism of action.
The structure of the DHR38 ligand binding domainlarval instar of the honeybee. Given the reported activity
of these ecdysteroids, it seems reasonable to expect offers an intriguing framework from which several clues
about the mechanism of DHR38 action can begin to bethat at least one of the pathways governing these re-
sponses is mediated by the DHR38 pathway described elucidated. Although we cannot formally rule out the
possibility that a ligand could bind to DHR38 by anhere. Further support for the hypothesis that a DHR38/
USP heterodimer may play an essential role in ecdyste- induced-fit mechanism or to an allosteric site, we con-
sider both possibilities unlikely. The tight spatial con-roid signaling comes from the observation that DHR38
and USP are each required for ecdysteroid-induced cuti- straints forced upon the protein by the four phenylala-
nines within the conventional ligand binding pocketcle formation during Drosophila development (Perrimon
et al., 1985; Kozlova et al., 1998; Hall and Thummel, (Figures 5C and 5D) almost completely exclude the in-
duced-fit possibility. Likewise, our inability to demon-1998). A key to the future characterization of this devel-
opmental pathway will be the use of the DHR38/USP strate any type of specific ligand binding to the protein
under a variety of conditions (e.g., in the presence orheterodimer and ecdysteroid agonists as tools to iden-
tify downstream target genes, which at present remain absence of activated heterodimer partner) using a num-
ber of assays argues against the existence of a secondunknown.
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ing domain, including hinge region, of EcR (amino acids 330–878)binding site on the protein. An equally important finding
was amplified by PCR and inserted in pA5C vector using the EcoRVis the loss of the charge clamp (Figure 6), which funda-
restriction site. The following oligonucleotides PCR primers werementally excludes the DHR38 ligand binding domain
used to construct A5C-GAL4-DHR38AF-2: 5-ATAGATATCGT
from interacting with the p160 family of coactivators in CAAGGAAGTGGTGCGCAC-3 and 5-TATGCTAGCTATGGTGCGG
a conventional fashion (Rosenfeld and Glass, 2001). This GTACCAGGTCCTC-3, which utilize EcoRV and NheI restriction
sites, respectively. For A5C-VP16-USP, a CMX3 primer and thefinding is consistent with our inability to observe any
following oligonucleotide was used: 5-AAAGGTACCAGGATGGAinteractions with these coactivators in either cell-based
CAACTGCGACCAG-3, which utilizes an ASP718 restriction site.or biochemical assays (data not shown). Taken together,
The PCR products from each of these reactions was then clonedour results provide strong evidence that the ecdysteroid
into A5C with standard techniques.
response by the DHR38/USP heterodimer occurs through
a mechanism that is different from the well-documented,
Transfection Assaysdirect binding paradigm that has been exhibited for nu-
SL2 cells were plated at a density of 8  105 cells/ml (100 l/well)merous other RXR heterodimers (Chawla et al., 2001).
in 96-well opaque plates with clear bottom (Costar) and allowed toTherefore, the signaling pathway between ecdysteroid
grow overnight. After17 hr of growth, 20 l of transfection mix was
and DHR38-mediated transcription must be transduced added per well. Transfection mix was prepared using the standard
in an atypical fashion. This mechanism, however, still ap- calcium phosphate method with 1HEPES (pH 7.4) and contained
pears to require the AF-2 domain of DHR38 (Figure 1). 15 ng of each receptor, 50 ng of LUC reporter, 20 ng of internal
control GAL plasmid (which drives high-level expression of the E.Although it is not clear how the AF-2 contributes to
coli -galactosidase protein), and carrier DNA (pGEM) up to 150 ngreceptor transactivation, our data support a model in
total DNA for each well that was transfected. Cells were dosed withwhich ecdysteroids may indirectly activate DHR38, per-
20 l of the indicated compounds in media 6 hr posttransfection
haps by recruiting a specific cofactor to the DHR38/ and harvested 17 hr after dosing with hormone. The media in each
USP heterodimer. In this model, it is tempting to specu- well was replaced with 50 l of luciferase lysis buffer (3 mM tricine
late that ecdysteroids may activate the cofactor through [pH 7.8], 0.8 mM magnesium acetate, 0.02 mM EDTA, 0.15 mM ATP,
100 mM 2-mercaptoethanol, 1% Triton X-100, 0.5 mM Coenzymea direct interaction or through a second message path-
A (Sigma), and 0.5 mM D-luciferin, sodium salt (Molecular Probes),way. Regardless, the requirement for a DHR38 cofactor
and the plates were incubated at room temperature under aluminumis implicit in our findings and its future characterization
foil for 60 s. Light units were then read with a Dynatech MR5000
will be important to fully understand the mechanism of luminometer. After reading light units, 125 l of ONPG buffer (60
this new signal transduction pathway. mM Na2HPO4 and 40 mM NaH2PO4) containing 2 mg/ml ONPG was
added/well. After color development at 37C, the plate was read on
a Dyntech MR5000 plate reader (test filter 410 nm, reference filterPerspectives
630 nm). Relative light units (RLU) reported were calculated as ([lightThe principles of DHR38 action may be of help in charac-
units/OD 420]  reaction time in minutes).
terizing its mammalian orthologs, the NGFI-B family of
receptors. Like DHR38, these orphan receptors can
RNAifunction as monomers or RXR heterodimers and be acti-
For RNAi, the following oligonucleotides were generated againstvated by RXR ligands (Giguere, 1999). However, little is
the EcR LBD, which incorporate a 5 T7 RNA polymerase bindingknown about the agonist or cofactor specificity of these
site: 5-TTAATACGACTCACTATAGGGAGAGGAGGTCACGTCCTC
proteins or the mechanistic details of how they promote CTC-3 and 5TTAATACGACTCACTATAGGGAGACTTCTTCGCATC
transactivation. Our analysis shows that the overall con- GCAGCT-3. Primers were used to PCR a fragment off of the
servation between DHR38 and the three mammalian A5C-EcR plasmid. The product was purified and quantified by OD
260 and used to generate dsRNA with the T7 MEGAscript kit (Am-NGFI-B family members is well conserved in the putative
bion). RNA was resuspended in water and directly added to theligand binding pocket. Indeed, as shown for DHR38,
normal tranfection mix described above.modeling of the 3D structure of the NGFI-B receptors
predicts the absence of both a ligand binding pocket
and a coactivator binding site, suggesting that a com- Generation of the hs-GAL4-DHR38 Transgenic Flies
and Larval Organ Culturemon mechanism of action may exist for governing these
Hs-GAL4-EcR is described in Kozlova and Thummel (2002). To gen-receptors in mammals. Given these similarities between
erate the hs-GAL4-DHR38 construct, DNA encoding the DrosophilaDHR38 and its vertebrate counterparts, it should not be
DHR38 LBD, including the hinge region (amino acids 287–527), wassurprising that, like many other insect signaling path-
amplified by PCR from the cTK11 cDNA clone (Sutherland et al.,
ways, there is a lot to learn from the fly. 1995), and this fragment was inserted between the EcoRI and BamHI
sites of pCaSpeR-hs-GAL4act (Kozlova and Thummel, 2002). The
Experimental Procedures junction between GAL4 DBD and DHR38, as well as DHR38 LBD
sequences in the resulting construct, were verified by DNA sequence
Ecdysteroids analysis. This P element construct was introduced into the germline
Ecdysteroids used were a generous gift from J.T. Warren and L.I. of w1118 flies by standard transformation procedures. A homozygous
Gilbert (University of North Carolina). Stock solutions of compounds viable hs-GAL4-DHR38 insertion on the third chromosome was used
were dissolved in a 1:1 mixture of ethanol to DMSO or in 100% for all studies reported here. Hs-GAL4-DHR38; UAS-nlacZ or hs-
ethanol. GAL4-EcR; UAS-nlacZ third instar larvae were maintained on food
containing 0.5% bromophenol blue and partial blue gut animals
(Andres and Thummel, 1994) were heat treated for 30 min at 37CCell Culture and Plasmids
SL2 Schneider cells were grown in Schneider’s Drosophila medium in a water bath in plastic vials with food. Animals were selected at
8 hr before puparium formation, and larval organs were cultured in(Gibco) supplemented with 6.5% super-stripped fetal bovine serum
(Gemini) and 1% antibiotic-antimycotic (Gibco) in atmospheric con- the presence of 10	6M -ecdysone or 10	6M 3-epi-20E as described
(Kozlova and Thummel, 2002). Tissues were then stained with X-galditions at 24C. Insect cell expression vectors pA5C-EcR, pA5C-
GAL4-DHR38, pADH-hspEcRE-LUC, and pADH-UAS-LUC were as for -galactosidase expression as described (Kozlova and Thum-
mel, 2002).described (Baker et al., 2000). For pA5C-GAL4-EcR, the ligand bind-
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